The patient has successfully survived gastric cancer for 6 years, and this detail cannot be ignored

Facing the risk of recurrence, Mr. Wu didn't dare to take it lightly. While undergoing postoperative chemotherapy, he reached out to Professor Zhang Minghui for tumor postoperative rehabilitation recommendations, hoping to develop a systematic rehabilitation plan tailored to his condition. This plan aimed to gradually recover from the physical trauma caused by surgery and chemotherapy while preventing tumor recurrence and metastasis.

The Lehexin Medical team provided rehabilitation recommendations based on assessment and analysis:

1. The patient adopted a "sandwich biscuit" type adjuvant chemotherapy regimen, which created conditions for conventional radical surgery. The patient's tumor burden was relatively low at this time, providing favorable conditions for vNKT cell therapy.

2. Although the visible tumors were removed, the pathological results still indicated a high risk of recurrence and metastasis due to vascular cancer thrombus and differentiation type. Conventional treatment generally ends at this point, but it cannot guarantee the absence of recurrence and metastasis. To consolidate the early "battle achievements," another effective treatment method was sought - vNKT immune cell therapy.

3. At the same time, positive psychology was incorporated to rebuild psychological state and establish confidence in recovery; dietary adjustments were made to change previous unhealthy lifestyle habits; and physical fitness was gradually restored through qigong practice.

In May 2019, Mr. Wu underwent vNKT cell immunotherapy. The initial regimen was one course per month, and after multiple follow-up examinations, no signs of recurrence or metastasis were observed, leading to a reduction in treatment frequency to one course every two months. As of February 2023, 30 courses have been completed. Mr. Wu has smoothly spent six years and achieved clinical cure.

Gastric cancer is a common malignant tumor in clinical practice. According to surveys, its incidence rate ranks fifth nationwide, and among all causes of cancer death, it ranks third^[1]. The treatment of advanced gastric cancer with radical gastrectomy combined with neoadjuvant chemotherapy has shown good results, reducing the degree of patient body damage, the incidence of complications, and shortening the recovery time. The application of neoadjuvant chemotherapy before radical gastrectomy can inhibit tumor cell activity, control the probability of tumor cell metastasis and diffusion during surgery, and reduce the rate of disease metastasis and recurrence^[2]. After comprehensive consideration, Mr. Wu adopted neoadjuvant chemotherapy, which earned him a greater chance of survival. Post-surgery recovery is a key point. Mr. Wu adopted Lehexin Medical's [post-tumor surgery recovery recommendations] to reduce the risk of recurrence, enhance immunity, resume normal work and life, and return to society.

Therefore, I hope that patients do not seek treatment in haste and leave regrets in their treatment. If you are unable to make a decision on the path of disease treatment, you can listen to Lehexin Medical's [post-tumor surgery recovery recommendations] and contact the assistant for advice.

Reference Source:

[1] Wang Shaoming, Zheng Rongshou, Han Bingfeng, et al. Analysis of the Age Characteristics of Incidence and Mortality of Malignant Tumors in the Chinese Population in 2022 [J]. China Cancer, 2024, 33(03):165-174.

[2] Liu Zhuang Clinical Effect Analysis of Radical Gastrectomy Combined with Neoadjuvant Chemotherapy for Advanced Gastric Cancer [J]. China Modern Drug Application, 2023, 17(22):112-114. DOI: 10.14164/j.cnki.cn11-5581/r.2023.22.030.

Edited/Typeset by: Zhao Runquan

Medically Reviewed by: Wang Ying